We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tirzepatide a novel anti diabetic molecule unfold dual action.
- Authors
Sweta; Gupta, Sumeet; Bansal, Seema; Devi, Siwani; Sharma, Sheenam; Laxmi; Deepa
- Abstract
This review article provides an in-depth examination of various aspects related to tirzepatide, a synthetic peptide given the positive signal by the "United States Food and Drug Administration" for managing type 2 diabetes. Beginning with an overview of diabetes introduction, epidemiology, and issues related to β-cell dysfunction, is explored in the narrative. It further delves into the significance of incretins in the context of diabetes and introduces tirzepatide as a novel "twincretin" owing to its dual agonistic activity on the glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors. The document delves into the chemistry and structure of tirzepatide, providing insights into its unique composition of 39 amino acids derived from native GLP-1, GIP, and semaglutide sequences. Tirzepatide's pharmacology, with a focus on its pharmacokinetic characteristics, and its mechanism of action (MOA) are extensively discussed. Notably, tirzepatide exhibits a preference for GIP receptors, leading to effective reduction of hyperglycemia and positive effects on pancreatic β-cells. Clinical trials examining tirzepatide's impact on glycemic and obesity control are detailed, demonstrating its efficacy in reducing body weight and appetite. Furthermore, the review article explores tirzepatide's effects on cardiovascular and kidney function, highlighting potential renal benefits for diabetic and elevated cardiovascular risk individuals. The narrative also addresses the association between tirzepatide and NAFLD, emphasizing potential benefits in mitigating NAFLD outcomes. Additionally, a comprehensive overview of tirzepatide's side effects, supported by scientific trials, is presented in this article. In conclusion, this review article provides a thorough examination of tirzepatide's multifaceted impact on diabetes management, shedding light on its pharmacological properties, clinical implications, and potential side effects. The information presented contributes to a comprehensive understanding of tirzepatide's role in the evolving landscape of T2D therapeutics.
- Subjects
CARDIOVASCULAR disease prevention; KIDNEY disease prevention; GLUCAGON-like peptide-1 agonists; NON-alcoholic fatty liver disease; INCRETINS; GLYCEMIC control; BODY weight; PANCREATIC beta cells; HYPOGLYCEMIC agents; INSULIN; GASTROINTESTINAL hormones; PHARMACY information services; TYPE 2 diabetes; MOLECULAR structure; DRUG interactions; DRUG efficacy; OBESITY; CELL receptors; PHARMACODYNAMICS; CHEMICAL inhibitors
- Publication
Discover Public Health, 2024, Vol 21, Issue 1, p1
- ISSN
3005-0774
- Publication type
Article
- DOI
10.1186/s12982-024-00200-2